(PharmaNewsWire.Com, April 11, 2019 ) The Research Report on Antinuclear Antibody Test Market provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecast and market share analysis.
Major Insights Covered in research Study:
It provides valuable information on the products, techniques, and diseases in the ANA testing market. Details on regional markets for these segments are also presented in this report. Also, leading players are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this Antinuclear Antibody Test Market.
The abovementioned information will benefit buyers by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on growth opportunities.
Market Segment by Diseases for Antinuclear Antibody Test Market;
Rheumatoid Arthritis Systemic Lupus Erythematosus Sjögren’s Syndrome Scleroderma Other Diseases
Market Segment by Techniques for Antinuclear Antibody Test Market;
Based on techniques, the Antinuclear Antibody Test Market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market due to the expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.
Geographical Growth Insights for Antinuclear Antibody Test Market;
North America is the largest regional segment in the ANA testing market, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American market is primarily driven by the high incidence of autoimmune diseases, growing population and healthcare spending, and growth in the number of individuals covered under medical insurance in the U.S.
Major Key Players Impacting the Global Market for Antinuclear Antibody Test;
The major players in the antinuclear antibody test market are Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).
Thermo Fisher Scientific was the leading player in the global ANA testing market. The company has a strong presence in North America, Europe, Asia, and Latin America. It focuses on expanding its presence in the ANA testing market by strategically investing in research and development activities, which enables it to launch new products in the Antinuclear Antibody Test Market.
Thermo Fisher Scientific introduced the Phadia 2500E Laboratory System and EliA PR3s, MPOs, and GBM Assays. Such launches have strengthened the company’s portfolio in the ANA testing market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
